#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent Myelofibrosis Neuroendocrine carcinoma Liposarcoma Alveolar proteinosis Fontan procedure Sickle cell disease Polycystic liver disease Progressive multifocal leukoencephalopathy Vaginal cancer B-cell small lymphocytic lymphoma recurrent Ichthyosis Leukocyte adhesion deficiency Oesophageal adenocarcinoma stage II Cutaneous T-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    IgA nephropathy – Treatment Kearns-Sayre syndrome – Trials in Disease Lennox-Gastaut syndrome – Basic Information Castleman’s disease – Basic Information Alagille syndrome – Diagnostics Mantle cell lymphoma stage III – Diagnostics Medulloblastoma recurrent – Basic Information Isodicentric chromosome 15 syndrome – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Advanced systemic mastocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VG801-2 Digitoxin Ep0042 IMA401 Sabestomig Guanfacine Phenol, Liquefied Sodium Iodide (123 I) [18F]-Altanserin Epinephrine Galcanezumab Rhh646 Vorasidenib GS-1720 SGN-ALPV ATIRMOCICLIB Clemastine Febuxostat Hemihydrate Hyoscine Butylbromide Ruzasvir More therapies…

    Learn about Your Condition

    Psoriasis Hypoxia Endometriosis Systemic scleroderma Necrotising myositis Myositis Streptococcal infection Medication overuse headache Pharyngeal cancer stage II Morning sickness Habitual abortion Neurodermatitis Hereditary ataxia Basal cell naevus syndrome Hydrocele More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evang. Kliniken Essen-Mitte, ZIM – Zentrum für Integrative…

Evang. Kliniken Essen-Mitte, ZIM – Zentrum für Integrative Medizin und Naturheilkunde

Am Deimelsberg 34a, Essen, 45276, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and Safety of Amara‑Tropfen Dilution vs Placebo in Patients with Irritable Bowel Syndrome

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Germany

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!